NCT00079079 Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor Status COMPLETED Phase PHASE2
NCT00079040 Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00078949 Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE3
NCT00077545 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction Status COMPLETED Phase PHASE2
NCT00077389 Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma Status UNKNOWN Phase PHASE2
NCT00077311 Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00077103 Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00077051 Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat) Status COMPLETED Phase PHASE1
NCT00076310 OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer Status COMPLETED Phase PHASE2
NCT00075738 Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer Status UNKNOWN Phase PHASE2
NCT00075699 Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma Status COMPLETED Phase PHASE3
NCT00072787 Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00072527 Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00072332 Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00072215 Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors Status TERMINATED Phase PHASE3
NCT00072124 Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma Status COMPLETED Phase PHASE3
NCT00070200 Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma Status COMPLETED Phase PHASE1
NCT00069966 Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse Status UNKNOWN Phase PHASE2
NCT00069953 Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Status COMPLETED Phase PHASE2
NCT00069875 A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2